Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Erythropoietin Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Erythropoietin Drugs Market, by Type, 2020-2030 (USD Billion)
1.2.3. Erythropoietin Drugs Market, by Product, 2020-2030 (USD Billion)
1.2.4. Erythropoietin Drugs Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Erythropoietin Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Erythropoietin Drugs Market Dynamics
3.1. Erythropoietin Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising incidence of chronic diseases
3.1.1.2. Rising number of CKD cases
3.1.2. Market Challenges
3.1.2.1. Launch of alternative drugs
3.1.2.2. Increased demand for EPO Side effects
3.1.3. Market Opportunities
3.1.3.1. Rise in trends of commercialization for erythropoietin biosimilars
3.1.3.2. Increase in level of awareness regarding benefits of EPO therapeutics
Chapter 4. Global Erythropoietin Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Erythropoietin Drugs Market, by Type
5.1. Market Snapshot
5.2. Global Erythropoietin Drugs Market by Type, Performance - Potential Analysis
5.3. Global Erythropoietin Drugs Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Erythropoietin Drugs Market, Sub Segment Analysis
5.4.1. Biologics
5.4.2. Biosimilars
Chapter 6. Global Erythropoietin Drugs Market, by Product
6.1. Market Snapshot
6.2. Global Erythropoietin Drugs Market by Product, Performance - Potential Analysis
6.3. Global Erythropoietin Drugs Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
6.4. Erythropoietin Drugs Market, Sub Segment Analysis
6.4.1. Erythropoietin
6.4.2. Darbepoetin-alfa
Chapter 7. Global Erythropoietin Drugs Market, by Application
7.1. Market Snapshot
7.2. Global Erythropoietin Drugs Market by Application, Performance - Potential Analysis
7.3. Global Erythropoietin Drugs Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
7.4. Erythropoietin Drugs Market, Sub Segment Analysis
7.4.1. Cancer
7.4.2. Renal Diseases
7.4.3. Neurology
7.4.4. Others
Chapter 8. Global Erythropoietin Drugs Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Erythropoietin Drugs Market, Regional Market Snapshot
8.4. North America Erythropoietin Drugs Market
8.4.1. U.S. Erythropoietin Drugs Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Product breakdown estimates & forecasts, 2020-2030
8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Erythropoietin Drugs Market
8.5. Europe Erythropoietin Drugs Market Snapshot
8.5.1. U.K. Erythropoietin Drugs Market
8.5.2. Germany Erythropoietin Drugs Market
8.5.3. France Erythropoietin Drugs Market
8.5.4. Spain Erythropoietin Drugs Market
8.5.5. Italy Erythropoietin Drugs Market
8.5.6. Rest of Europe Erythropoietin Drugs Market
8.6. Asia-Pacific Erythropoietin Drugs Market Snapshot
8.6.1. China Erythropoietin Drugs Market
8.6.2. India Erythropoietin Drugs Market
8.6.3. Japan Erythropoietin Drugs Market
8.6.4. Australia Erythropoietin Drugs Market
8.6.5. South Korea Erythropoietin Drugs Market
8.6.6. Rest of Asia Pacific Erythropoietin Drugs Market
8.7. Latin America Erythropoietin Drugs Market Snapshot
8.7.1. Brazil Erythropoietin Drugs Market
8.7.2. Mexico Erythropoietin Drugs Market
8.8. Middle East & Africa Erythropoietin Drugs Market
8.8.1. Saudi Arabia Erythropoietin Drugs Market
8.8.2. South Africa Erythropoietin Drugs Market
8.8.3. Rest of Middle East & Africa Erythropoietin Drugs Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Teva Pharmaceutical Industries Ltd.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Johnson & Johnson Services, Inc.
9.3.3. Intas Pharmaceuticals Ltd.
9.3.4. Novartis AG
9.3.5. Amgen, Inc.
9.3.6. F. Hoffmann-La Roche Ltd.
9.3.7. LG Chem
9.3.8. Biocon
9.3.9. Sun Pharmaceutical Industries Ltd
9.3.10. Dr. Reddy's Laboratories Ltd
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption